The main reasons why cancer is so difficult to treatment

Authors

Keywords:

Cancer, Tumor, treatmnet

Downloads

Download data is not yet available.

Author Biography

Ali Adel Dawood, University of Mosul. College of Medicine. Department of Anatomy. Mosul

Department of Anatomy, College of Medicine

References

1. Copland M, Jorgensen HG, Holyoake TL. Evolving molecular therapy for chronic myeloid leukaemia-are we on target? Hematology [Internet]. 2005 [cited 01/09/2020]; 10:349–359. Disponible en: https://www.tandfonline.com/doi/abs/10.1080/10245330500234195

2. Fruhwirth GO, Kneilling M, de Vries IJM et al. The potential of in vivo imaging for optimization of molecular and cellular anti-cancer immunotherapies. Mol Imaging Biol[Internet]. 2018 [cited 01/09/2020]. Disponible en: https://doi.org/10.1007/s11307-018-1254-3.

3. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metabolism [Internet]. 2016[cited 01/09/2020]; 23(1):27-47. Disponible en: https://doi:10.1016/j.cmet.2015.12.006.

4. Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, Vander Heiden MG, Miller G, Drebin JA, Bar-Sagi D, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res[Internet]. 2015[cited 01/09/2020]; 75:544–553.Disponible en: https://doi.org/10.1158/0008-5472.CAN-14-2211

5. Wang Z, Liu F, Fan N, Zhou C, Li D, Macvicar T, Dong Q, Bruns CJ, Zhao Y. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies. Front Oncol[Internet]. 2020[cited 01/09/2020]; 10:589508.Disponible en:https://doi:10.3389/fonc.2020.589508.

6. Catenacci DVT. Next-generation clinical trials: Novel strategies toaddress the challenge of tumormolecular heterogeneity. Mol Oncol[Internet].2015[cited 01/09/2020]; 9:967–996. Disponible en:https://doi:10.1016/j.molonc.2014.09.011.

Downloads

Published

2020-11-30

How to Cite

1.
Dawood AA. The main reasons why cancer is so difficult to treatment. Univ. Méd. Pinareña [Internet]. 2020 Nov. 30 [cited 2025 Jun. 5];18(2):e605. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/605

Issue

Vol. 18 No. 2 (2022): Mayo-Agosto

Section

Letter to the Editor

License

Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).